Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1
PR Newswire associated2
PR Newswire associated3

Tags

Piramal-Pharma-Soluti

More Like This

PR Newswire associated0

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

PR Newswire associated0

Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky

PR Newswire associated0

Piramal Pharma Ltd. Continues to Invest In USA; $90M in Expansions of Two US Sites

PR Newswire associated0

Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site

PR Newswire associated0

Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities

PR Newswire associated0

Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities

PR Newswire associated0

Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited

PR Newswire associated0

Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us